x
African Health Sciences

    Book Now

    • 256(41)530021
    • info@africanhealthsciences.org
    African Health Sciences
    • info@africanhealthsciences.org
    • Give Feedback
    • Home
    • About Us
    • Staff
    • Focus & Scope
    • For Authors
    • More Links
      • About The Journal
      • Latest Articles
      • Journal Archives
      • Our Events
      • Faq’s
    • Contact Us
    Logo

    Contact Info

    • P. O. Box 7072 Kampala, Uganda
    • +256(41)530021
    • info@africanhealthsciences.org
    • ISSN 1680-6905
    • <!--
    • -->

    12Sep2017

    Evaluation of the adjuvant effect of Escherichia coli heat-labile enterotoxin mutant (LTK63) on the systemic immune responses to intranasally co-administered measles virus nucleoprotein. Part I: Antibody responses

    by admin,  0 Comments

    Evaluation of the adjuvant effect of Escherichia coli heat-labile enterotoxin mutant (LTK63) on the systemic immune responses to intranasally co-administered measles virus nucleoprotein. Part I: Antibody responses

    Joseph Erume and 2Harris Partidos
    lDepartment of Veterinary Parasitology and Microbiology, Makerere University Box 7062 Kampala, Uganda.
    2Department of Pathology and Infectious diseases, The Royal Veterinary College, London NWl OTU.

    ABSTRACT
    The adjuvanticity and immunogeniclty of the heat-labile enterotoxin (LT) ofEscherichia coliand of its non-toxic mutant, LTK63, was evaluated after Intranasal administration of CBA mice with recombinant measles virus nucleoprotein (rMVNP) with or without LTor LTK63.Both LTand LTK63were shown to be highly immunogenic with higher responses observed 4 weeks after the booster Immunization.

    Although the nucleoprotein was Immunogenic on Its own, mice Immunized with the nucleoprotein. plus wildtype LTproduced significantly high antibody responses (p<O.Ol). Mice that received the rMVNPwith LTK63also generated strongantibody responses to rMVNP.These antibodies were also significantly higher than those of rMVNPalone (p< 0.05).

    No significant differences were observed between groups of mice Immunized intranasally withfMVNP plus LTor LTK63(p> 0.05). Data on IgGantibody isotype profiles showed that IgG 1 and IgG 2a were predominant in mice immunized with rMVNP+ LTor LTK63whereasIgG 1 predominated when rMVNP was given on Its own implying that LT and LTK63 induce both Th1 and Th2-type immune responses. These results highlight the great potential of this non-toxic mutant of LTas a safe vaccine adjuvant.

    Related posts:

    Spinal African histoplamosis simulating tuberculous spondylitis

    Contraceptive security , information flow , and local adaptations: Family planning Morocco.

    Childhood bacterial meningitis in Mbarara Hospital, Uganda: antimicrobial susceptibility and outcome...

    Recent Posts

    • Editor’s choice: Tackling infectious diseases, NCDs and sexual reproductivehealth issues as we enter our 24th year of remarkable growth
    • Preconception and contraceptive care for women living with HIV/AIDSattending antiretroviral treatment clinics in Lagos State, Nigeria
    • Effects of SNPs on TNF-α and IL-10 cytokine expression in TB and HIVpatients in the Capricorn district, Limpopo Province, South Africa
    • Prevalence of Schistosomiasis in a neglected community, South western Nigeria at two points in time, spaced three years apart
    • Review of Leishmaniasis in the Middle East and North Africa

    Recent Comments

    No comments to show.

    Archives

    • April 2024
    • May 2019
    • April 2019
    • September 2018
    • August 2018
    • January 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017

    Categories

    • 2001 Issues
    • 2002 Issues
    • 2003 Issues
    • 2004 Issues
    • 2005 Issues
    • 2006 Issues
    • 2007 Issues
    • 2008 Issues
    • 2009 Issues
    • 2010 Issues
    • 2011 Issues
    • 2012 Issues
    • 2013 Issues
    • 2014 Issues
    • 2015 Issues
    • 2016 Issues
    • 2017 Issues
    • 2018 Issues
    • 2019 Issues
    • 2024 Issues
    • Articles
    • December issue
    • December Release
    • June Issue
    • June Release
    • March Issue
    • March Issue
    • March Release
    • News
    • number / volume 2
    • number /volume 1
    • number /volume 1
    • number /volume 1 2008
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2 special Issue
    • number 2 special Issue 2
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 4
    • number 4
    • number 4
    • number 4
    • number 4
    • number 4
    • number/ volume 3 2008
    • number/ volume 4 2008
    • number/volume 1
    • number/volume 1
    • number/volume 2
    • number/volume 2
    • number/volume 2 2008
    • number/volume 3
    • number/volume 3
    • number/volume 3
    • number/volume 4
    • number/volume1
    • September Issue
    • September Release
    • Special Edition
    • special Issue
    • Uncategorized
    • Vol. 24 No. 1 (2024)
    • volume 1
    • volume 1
    • volume 1
    • volume 2
    • volume 2
    • volume 2
    • volume 2
    • volume 2
    • volume 3
    • volume 3
    • volume 3
    • volume 3
    • volume 4
    • volume 4
    • volume 4
    • volume 4
    • volume1

    Categories

    • 2001 Issues
    • 2002 Issues
    • 2003 Issues
    • 2004 Issues
    • 2005 Issues
    • 2006 Issues
    • 2007 Issues
    • 2008 Issues
    • 2009 Issues
    • 2010 Issues
    • 2011 Issues
    • 2012 Issues
    • 2013 Issues
    • 2014 Issues
    • 2015 Issues
    • 2016 Issues
    • 2017 Issues
    • 2018 Issues
    • 2019 Issues
    • 2024 Issues
    • Articles
    • December issue
    • December Release
    • June Issue
    • June Release
    • March Issue
    • March Issue
    • March Release
    • News
    • number / volume 2
    • number /volume 1
    • number /volume 1
    • number /volume 1 2008
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2 special Issue
    • number 2 special Issue 2
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 4
    • number 4
    • number 4
    • number 4
    • number 4
    • number 4
    • number/ volume 3 2008
    • number/ volume 4 2008
    • number/volume 1
    • number/volume 1
    • number/volume 2
    • number/volume 2
    • number/volume 2 2008
    • number/volume 3
    • number/volume 3
    • number/volume 3
    • number/volume 4
    • number/volume1
    • September Issue
    • September Release
    • Special Edition
    • special Issue
    • Uncategorized
    • Vol. 24 No. 1 (2024)
    • volume 1
    • volume 1
    • volume 1
    • volume 2
    • volume 2
    • volume 2
    • volume 2
    • volume 2
    • volume 3
    • volume 3
    • volume 3
    • volume 3
    • volume 4
    • volume 4
    • volume 4
    • volume 4
    • volume1

    Archives

    • April 2024
    • May 2019
    • April 2019
    • September 2018
    • August 2018
    • January 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017

    Tags

    Achives Latest News


    ISSN 1680-6905

    • P. O. Box 7072 ,Kampala, Uganda
    • Call Us: 256(41)530021
    • info@africanhealthsciences.org

    Latest Activities

    Usefull Link

    • About AHS
    • Services
    • Focus & Scope
    • Our Articles
    • Contact Us

    Subscribe

    For research updates from African Health Sciences, sign up now!

      African Health Sciences © All Right Reserved